spacer
home > ebr > summer 2003 > mass-based fraction collection of crude synthetic peptides in analytical and preparative scale for cancer treatment
PUBLICATIONS
European Biopharmaceutical Review

Mass-Based Fraction Collection of Crude Synthetic Peptides in Analytical and Preparative Scale for cancer treatment

Synthetic peptides become more and more important as drug candidates in the treatment of a variety of diseases. A particular therapeutic focus for synthetic peptides is cancer treatment (1, 2). In order to keep pace with the growing number of newly synthesised peptides, peptide purification should not represent a bottleneck in the drug discovery process. Since the target masses of synthetic peptides are well known, mass-based fraction collection represents an efficient technique for their purification. In contrast to fraction triggering with less specific detectors, employing a mass selective detector only leads to the purification of the target mass in each run. Consequently, it is not necessary to pick out the compound of interest from a series of redundant fractions.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Ralf Moritz, Application Chemist at Agilent Technologies, and Nicola O'Reilly at Cancer Research UK
Ralf Moritz studied Chemistry at Gerhard Mercator University, Germany, before moving to McMaster University in Canada for a year in 1993.

He completed his PhD thesis at Robert Koch-Institute, Berlin in 2000 before undertaking research work at the Max Delbrück Centrum for Molecular Medicine, Berlin. Since 2001 Ralf has been an Application Chemist at Agilent Technologies, Germany.


Nicola O'Reilly received a BSc (Hons) in Chemistry from Southampton University in 1987. She then joined Cancer Research UK (then Imperial Cancer Research Fund), running the peptide synthesis laboratory.

In 1994 Nicola completed a master's degree in Biochemistry at King's College London. In October 1999 she set up a new 2D gel electrophoresis facility and in July 2000 she took over the ICRF Protein Isolation Service. After the formation of Cancer Research UK she opened up peptide synthesis and protein isolation to new Cancer Research UK clients.


spacer
Ralf Moritz
spacer
spacer
spacer
Nicola O'Reilly
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement